EMA · 174 alerts

EMA — medicine safety communications

Official information published by European Medicines Agency. Each entry links to the original page, which is authoritative. www.ema.europa.eu ↗

RSS feed for this list · Get e-mail alerts

Filters

Search in this list Category Hazard Country Year Serious risk only Clear

23 June 2021EMA

Vaxzevria (previously COVID-19 Vaccine AstraZeneca): safety signal

Safety signalMedicine safety communications

10 June 2021EMA

Venclyxto: type ii variation

Type II variationMedicine safety communications

3 June 2021EMA

INOmax: quality defect

Quality defectMedicine safety communications

2 June 2021EMA

Vaxzevria (previously COVID-19 Vaccine AstraZeneca): type ii variation

Type II variationMedicine safety communications

26 April 2021EMA

Jcovden (previously COVID-19 Vaccine Janssen): safety signal

Safety signalMedicine safety communications

15 April 2021EMA

Eylea: adverse event

Adverse eventMedicine safety communications

13 April 2021EMA

Vaxzevria (previously COVID-19 Vaccine AstraZeneca): safety signal

Safety signalMedicine safety communications

26 March 2021EMA

Respreeza: medicine shortage

Medicine shortageMedicine safety communications

25 March 2021EMA

Tecentriq: adverse event

Adverse eventMedicine safety communications

24 March 2021EMA

Vaxzevria (previously COVID-19 Vaccine AstraZeneca): safety signal

Safety signalMedicine safety communications

24 March 2021EMA

Xeljanz: safety signal

Safety signalMedicine safety communications

22 March 2021EMA

Strimvelis: adverse event

Adverse eventMedicine safety communications

18 March 2021EMA

Zolgensma: type ii variation

Type II variationMedicine safety communications

17 February 2021EMA

Lojuxta: post-authorisation measure

Post-authorisation measureMedicine safety communications

12 February 2021EMA

Respreeza: quality defect

Quality defectMedicine safety communications

4 February 2021EMA

Alkindi: safety signal

Safety signalMedicine safety communications

23 January 2021EMA

Nucala: medicine shortage

Medicine shortageMedicine safety communications

23 December 2020EMA

Zerbaxa: quality defect

Quality defectMedicine safety communications

23 December 2020EMA

Kaletra: quality defect

Quality defectMedicine safety communications

15 December 2020EMA

Metamizole: periodic safety update report

Periodic safety update reportMedicine safety communications

1 December 2020EMA

Gliolan: type ii variation

Type II variationMedicine safety communications

12 November 2020EMA

Tecfidera: type ii variation

Type II variationMedicine safety communications

10 November 2020EMA

Gilenya: periodic safety update report

Periodic safety update reportMedicine safety communications

4 November 2020EMA

Ondexxya: adverse event

Adverse eventMedicine safety communications